Literature DB >> 2512504

Human abuse liability assessment by measurement of subjective and physiological effects.

D R Jasinski1, J E Henningfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2512504

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN： 1046-9516


× No keyword cloud information.
  9 in total

1.  Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder.

Authors:  Azmi F Nasser; Mark K Greenwald; Bradley Vince; Paul J Fudala; Philip Twumasi-Ankrah; Yongzhen Liu; J P Jones; Christian Heidbreder
Journal:  J Clin Psychopharmacol       Date:  2016-02       Impact factor: 3.153

2.  Opiate Antagonists Do Not Interfere With the Clinical Benefits of Stimulants in ADHD: A Double-Blind, Placebo-Controlled Trial of the Mixed Opioid Receptor Antagonist Naltrexone.

Authors:  Thomas J Spencer; Pradeep Bhide; Jinmin Zhu; Stephen V Faraone; Maura Fitzgerald; Amy M Yule; Mai Uchida; Andrea E Spencer; Anna M Hall; Ariana J Koster; Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2018 Jan/Feb       Impact factor: 4.384

3.  Cardiovascular and Subjective Effects of the Novel Adenosine A(2A) Receptor Antagonist SYN115 in Cocaine Dependent Individuals.

Authors:  Sd Lane; Ce Green; Jl Steinberg; L Ma; Jm Schmitz; N Rathnayaka; Sd Bandak; S Ferre; Fg Moeller
Journal:  J Addict Res Ther       Date:  2012-03-28

4.  Neurodevelopmental liabilities in alcohol dependence: central serotonin and dopamine dysfunction.

Authors:  Claudio A Naranjo; Alan Y Chu; Lescia K Tremblay
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

5.  The Mixed Opioid Receptor Antagonist Naltrexone Mitigates Stimulant-Induced Euphoria: A Double-Blind, Placebo-Controlled Trial of Naltrexone.

Authors:  Thomas J Spencer; Pradeep Bhide; Jinmin Zhu; Stephen V Faraone; Maura Fitzgerald; Amy M Yule; Mai Uchida; Andrea E Spencer; Anna M Hall; Ariana J Koster; Leah Feinberg; Sarah Kassabian; Barbara Storch; Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2018 Mar/Apr       Impact factor: 4.384

6.  Comparison of Caffeine and d-amphetamine in Cocaine-Dependent Subjects: Differential Outcomes on Subjective and Cardiovascular Effects, Reward Learning, and Salivary Paraxanthine.

Authors:  Scott D Lane; Charles E Green; Joy M Schmitz; Nuvan Rathnayaka; Wendy B Fang; Sergi Ferré; F Gerard Moeller
Journal:  J Addict Res Ther       Date:  2014

7.  Abuse Potential of Lemborexant, a Dual Orexin Receptor Antagonist, Compared With Zolpidem and Suvorexant in Recreational Sedative Users.

Authors:  Ishani Landry; Nancy Hall; Jagadeesh Aluri; Gleb Filippov; Larisa Reyderman; Beatrice Setnik; Jack Henningfield; Margaret Moline
Journal:  J Clin Psychopharmacol       Date:  2022-06-24       Impact factor: 3.118

8.  Nicotine levels after IV nicotine and cigarette smoking in men.

Authors:  Nancy K Mello; Mackenzie R Peltier; Haley Duncanson
Journal:  Exp Clin Psychopharmacol       Date:  2013-05-06       Impact factor: 3.492

9.  Foods are differentially associated with subjective effect report questions of abuse liability.

Authors:  Erica M Schulte; Julia K Smeal; Ashley N Gearhardt
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.